Patients must demonstrate adequate organ function as defined below; all screening labs to be obtained =< 14 days prior to registration; (Note: screening labs will be repeated again on cycle 1 day 1 [C1D1] if they were performed outside of the =< 4 day window)
Adequate labs
Adequate labs
Adequate organ function as appropriate for the disease under study. All screening laboratory tests should be performed within 10 days of treatment initiation.
Have adequate organ function (all screening labs should be performed within 15 days prior to study treatment):
Demonstrate adequate organ function, all screening labs should be performed within 14 days prior to registration
iC9-CAR19 CELL INFUSION: Demonstrate adequate renal and hepatic function; all screening labs to be obtained within 24 hrs prior to cell infusion
Demonstrate adequate organ function; all screening laboratory tests should be performed within 7 days of treatment initiation
Demonstrate adequate organ function, all screening labs should be performed within 10 days of study drug administration
Foundation for the Accreditation of Cellular Therapy (FACT) labs and final test results available prior to infusion into the patient (copy of labs included in appendices); in the second donation from the donor, the FACT labs must be redrawn within 30 days of initiation of apheresis; positive serologies are not repeated as they remain positive for lifetime
Demonstrate adequate organ function, screening labs that include hematology and chemistry labs should be performed within 14 days of registration on the study
All screening labs should be performed within 14 days (+3 working days) of treatment initiation: hemoglobin >= 9 g/dL or >= 5.6 mmol/L;
Patients must have adequate labs within 7 days of treatment unless cytopenia is thought to be due to underlying disease
Have adequate organ function, with all screening labs performed within 7 days of treatment initiation.
Demonstrate adequate organ function, all screening labs should be performed within 14 days of treatment initiation
Demonstrate adequate organ function, all screening labs should be performed within 6 weeks of treatment initiation
Leukocytes >= 2,000/mcL (labs should be performed within 14 days of treatment initiation)
Have adequate organ function (all screening labs should be performed within 15 days prior to treatment initiation):
Use of hydroxyurea within 7 days prior to screening labs
Specific ranges/levels of Screening labs that are acceptable per protocol.
Satisfactory results of screening safety labs, serum testosterone test and drug test
VTE risk score >= 1, using labs drawn within 28 days of consent
Labs required for enrollment (prior to microinjection):
Demonstrate adequate organ function, all screening labs must be performed within 10 days of treatment initiation; labs must meet eligibility criteria within 4 days of cycle 1 day 1
